Alpha 1-antitrypsin deficiency history and symptoms: Difference between revisions

Jump to navigation Jump to search
 
Line 6: Line 6:
Alpha 1-antitrypsin deficiency (A1AD) may have delayed onset of [[symptoms]] [[newborns]]. As a patient ages, [[Liver Diseases|liver dysfunction]] and deterioration will occur. The hallmark of AATD is [[dyspnea]]. A positive history of [[dyspnea]] and [[Cirrhosis|liver cirrhosis]] or [[chronic hepatitis]] is suggestive of AATD. The presentation of [[disease]] varies depending on the type of [[mutation]] associated with AATD. [[Symptoms]] of alpha-1 antitrypsin deficiency include [[shortness of breath]], [[wheezing]], [[rhonchi]] and [[rales]] associated with [[Infections|recurring respiratory infections]] and obstructive [[asthma]] that does not respond to treatment.
Alpha 1-antitrypsin deficiency (A1AD) may have delayed onset of [[symptoms]] [[newborns]]. As a patient ages, [[Liver Diseases|liver dysfunction]] and deterioration will occur. The hallmark of AATD is [[dyspnea]]. A positive history of [[dyspnea]] and [[Cirrhosis|liver cirrhosis]] or [[chronic hepatitis]] is suggestive of AATD. The presentation of [[disease]] varies depending on the type of [[mutation]] associated with AATD. [[Symptoms]] of alpha-1 antitrypsin deficiency include [[shortness of breath]], [[wheezing]], [[rhonchi]] and [[rales]] associated with [[Infections|recurring respiratory infections]] and obstructive [[asthma]] that does not respond to treatment.
==Histroy and Symptoms==
==Histroy and Symptoms==
*The hallmark of AATD is [[dyspnea]]. A positive history of [[dyspnea]] and [[liver cirrhosis]] or [[chronic hepatitis]] is suggestive of AATD.<ref>American Thoracic Society, Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency, Am Rev Respir Dis 1989; 140: 1494-1497.</ref> <ref>Eriksson, S. Alpha 1 – antitrypsin Deficiency: Lessons Learned from the Bedside to the Gene and Back Again: Historic Perspectives, Chest 1989; 95: 181-189. PMID 2642407</ref> <ref>Rovner, M.S., Stoller, J.K., Treatment of alpha-1 antitrypsin deficiency, in UpToDate, January 12, 1998.</ref> <ref>Stoller, J.K., Clinical Features and Natural History of Severe alpha-1 Antitrypsin Deficiency, Chest 1997; 111: 123s-128s. PMID 9184559</ref> <ref>Stoller, J.K., Extrapulmonary manifestations of alpha-1 antitrypsin deficiency, in UpToDate, March 13, 1997.</ref> <ref>Stoller, J.K., Clinical manifestations and natural history of alpha-1 antitrypsin deficiency, in UpToDate, January 3, 1997.</ref>
*The hallmark of AATD is [[dyspnea]]. A positive history of [[dyspnea]] and [[liver cirrhosis]] or [[chronic hepatitis]] is suggestive of AATD.<ref>American Thoracic Society, Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency, Am Rev Respir Dis 1989; 140: 1494-1497.</ref><ref>Eriksson, S. Alpha 1 – antitrypsin Deficiency: Lessons Learned from the Bedside to the Gene and Back Again: Historic Perspectives, Chest 1989; 95: 181-189. PMID 2642407</ref><ref>Rovner, M.S., Stoller, J.K., Treatment of alpha-1 antitrypsin deficiency, in UpToDate, January 12, 1998.</ref><ref>Stoller, J.K., Clinical Features and Natural History of Severe alpha-1 Antitrypsin Deficiency, Chest 1997; 111: 123s-128s. PMID 9184559</ref><ref>Stoller, J.K., Extrapulmonary manifestations of alpha-1 antitrypsin deficiency, in UpToDate, March 13, 1997.</ref><ref>Stoller, J.K., Clinical manifestations and natural history of alpha-1 antitrypsin deficiency, in UpToDate, January 3, 1997.</ref>
*The presentation of disease varies depending on the type of [[Mutations|mutation]] associated with AATD. The initial [[symptoms]] include cough associated with [[Sputum|sputum production]] and [[wheezing]]. These [[symptoms]] are initially intermittent
*The presentation of disease varies depending on the type of [[Mutations|mutation]] associated with AATD. The initial [[symptoms]] include cough associated with [[Sputum|sputum production]] and [[wheezing]]. These [[symptoms]] are initially intermittent


Line 14: Line 14:
*Other associations include [[panniculitis]] and [[Antineutrophil cytoplasmic antibody|cytoplasmic antineutrophil cytoplasmic antibody‒positive vasculitis]].  
*Other associations include [[panniculitis]] and [[Antineutrophil cytoplasmic antibody|cytoplasmic antineutrophil cytoplasmic antibody‒positive vasculitis]].  


*It is important to have a high level of suspicion for AATD in the differential diagnosis as the presentation is very similar to some of the common illnesses such as [[asthma]], [[COPD]], or [[Chronic cough, severe cold|chronic cough]].
*It is important to have a high level of suspicion for AATD in the differential diagnosis as the presentation is very similar to some of the common illnesses such as [[asthma]], [[COPD]], or [[Chronic cough, severe cold|chronic cough]].


*Symptoms of alpha-1 antitrypsin deficiency include:
*Symptoms of alpha-1 antitrypsin deficiency include:
Line 22: Line 22:
** Obstructive [[asthma]] that does not respond to treatment
** Obstructive [[asthma]] that does not respond to treatment


*Patients with alpha1 antitrypsin deficiency may develop [[emphysema]] during their third or fourth decade of life, even without a history of  [[smoking]]. Smoking however, accelerated progression of emphysema. Alpha1 antitrypsin deficiency is also associated with impaired [[liver function]] leading to [[cirrhosis]] and [[liver failure]].  
*Patients with alpha1 antitrypsin deficiency may develop [[emphysema]] during their third or fourth decade of life, even without a history of  [[smoking]]. Smoking accelerate progression of [[emphysema]]. Alpha1 antitrypsin deficiency is also associated with impaired [[liver function]] leading to [[cirrhosis]] and [[liver failure]].  
*Alpha 1 antitrypsin deficiency is a common cause requiring  [[liver transplantation]] in newborns.
*Alpha 1 antitrypsin deficiency is a common cause requiring  [[liver transplantation]] in newborns.



Latest revision as of 17:49, 22 January 2018

Alpha 1-antitrypsin deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Alpha 1-antitrypsin deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alpha 1-antitrypsin deficiency history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alpha 1-antitrypsin deficiency history and symptoms

CDC on Alpha 1-antitrypsin deficiency history and symptoms

Alpha 1-antitrypsin deficiency history and symptoms in the news

Blogs on Alpha 1-antitrypsin deficiency history and symptoms

Directions to Hospitals Treating Alpha 1-antitrypsin deficiency

Risk calculators and risk factors for Alpha 1-antitrypsin deficiency history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overview

Alpha 1-antitrypsin deficiency (A1AD) may have delayed onset of symptoms newborns. As a patient ages, liver dysfunction and deterioration will occur. The hallmark of AATD is dyspnea. A positive history of dyspnea and liver cirrhosis or chronic hepatitis is suggestive of AATD. The presentation of disease varies depending on the type of mutation associated with AATD. Symptoms of alpha-1 antitrypsin deficiency include shortness of breath, wheezing, rhonchi and rales associated with recurring respiratory infections and obstructive asthma that does not respond to treatment.

Histroy and Symptoms

  • Patients that smoke regularly develop dyspnea about 10 years earlier when compared to patients who do not smoke.
  • Dyspnea occurs with strenuous exercise initially but eventually results in limitation of mild activities with disease progession.
  • It is important to have a high level of suspicion for AATD in the differential diagnosis as the presentation is very similar to some of the common illnesses such as asthma, COPD, or chronic cough.
  • Symptoms of alpha-1 antitrypsin deficiency include:

References

  1. American Thoracic Society, Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency, Am Rev Respir Dis 1989; 140: 1494-1497.
  2. Eriksson, S. Alpha 1 – antitrypsin Deficiency: Lessons Learned from the Bedside to the Gene and Back Again: Historic Perspectives, Chest 1989; 95: 181-189. PMID 2642407
  3. Rovner, M.S., Stoller, J.K., Treatment of alpha-1 antitrypsin deficiency, in UpToDate, January 12, 1998.
  4. Stoller, J.K., Clinical Features and Natural History of Severe alpha-1 Antitrypsin Deficiency, Chest 1997; 111: 123s-128s. PMID 9184559
  5. Stoller, J.K., Extrapulmonary manifestations of alpha-1 antitrypsin deficiency, in UpToDate, March 13, 1997.
  6. Stoller, J.K., Clinical manifestations and natural history of alpha-1 antitrypsin deficiency, in UpToDate, January 3, 1997.


Template:WikiDoc Sources